ArticleCardiovascular diagnosis and therapy2021

Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study.

Stephen J Nicholls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.